List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 41 studies with search of: Tipranavir OR Aptivus[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
2 Completed Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
Condition: HIV Infections
Intervention: Drug: tipranavir/ritonavir (dose reduction)
3 Completed Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals
Condition: HIV Infections
Intervention: Drug: Protease inhibitor tipranavir
4 Completed
Has Results 		Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
5 Completed
Has Results 		Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)
Condition: HIV Infections
Interventions: Drug: Tipranavir (with low dose ritonavir);   Drug: Comparitor protease inhibitor(CPI)/low dose ritonavir(r)
6 Completed
Has Results 		Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir(r);   Drug: Comparitor Protease Inhibitor (CPI)
7 Unknown † Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir;   Drug: Rosuvastatin
8 Completed Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together
Condition: HIV Infection
Intervention: Drug: apricitabine
9 Completed
Has Results 		Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: Tipranavir
10 Completed Tipranavir/Ritonavir (TPV/r) in Protease Inhibitor (PI)-Experienced Patients With HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Tipranavir co-administered with low dose ritonavir
11 Completed
Has Results 		Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children
Condition: HIV Infections
Interventions: Drug: TPV oral solution;   Drug: RTV oral solution
12 Completed 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
Condition: HIV Infections
Intervention: Drug: Tipranavir
13 Unknown † An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
14 Completed Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
Condition: HIV Infections
Intervention: Drug: Tipranavir/Ritonavir
15 Available Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment
Condition: HIV Infections
Intervention: Drug: Tipranavir
16 Terminated
Has Results 		Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
17 Completed
Has Results 		Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy
Condition: HIV Infections
Intervention: Drug: tipranavir
18 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
19 Terminated
Has Results 		SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
20 Completed Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Efavirenz;   Drug: Indinavir/ritonavir;   Drug: Nelfinavir;   Drug: Saquinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Atazanavir;   Drug: Atazanavir/ritonavir;   Drug: Fos-amprenavir/ritonavir;   Drug: Tipranavir/ ritonavir;   Drug: Darunavir/ritonavir

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services